About Antheia

Antheia is a biotechnology company unlocking the medicinal power of nature with its rapid response biomanufacturing processes for essential medicines. Antheia uses synthetic biology to surpass the limits of conventional drug manufacturing and discovery. By reconstructing complex molecules in yeast, Antheia can produce APIs without the use of medicinal plants, transforming the pharmaceutical supply chain and ensuring reliable, consistent, and widespread availability to essential medicines.

Company Highlights
Year Founded

2015

icon-altEmployees

58

Location (HQ)

USA

Since Last Funding

2 years 2 months

Monthly Website Visitors

4.4K

icon-altTotal Investment Amt

$100M

Last Funding Round

Series Unknown

icon-altYoY Headcount Growth

1.75%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Manufacturing

Biotechnology

Biotechnology Research